![Michel Vounatsos](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michel Vounatsos
Director/Board Member at
REVVITY, INC.
Net worth: 3 M $ as of 31/05/2026
Profile
Michel Vounatsos is on the board of PerkinElmer, Inc. (United States), L’Institut de RYthmologie et Modélisation Cardiaque and n-Lorem Foundation and Chief Executive Officer & Director at Biogen, Inc. In his past career he occupied the position of President-Primary Care & Customer Business Line at Merck & Co., Inc. Mr. Vounatsos received an MBA from École des Hautes Études Commerciales de Paris.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
REVVITY, INC. 0.01% | 07/05/2026 | 13,977 ( 0.01% ) | 1 M $ | 31/05/2026 |
ZAI LAB LTD. 0.06% | 17/06/2026 | 727,870 ( 0.06% ) | 1 M $ | 31/05/2026 |
Michel Vounatsos active positions
| Companies | Position | Start |
|---|---|---|
| REVVITY, INC. | Director/Board Member | 01/03/2020 |
| ZAI LAB LIMITED | Director/Board Member | 07/01/2023 |
Biogen Idec, Inc. (North Carolina)
 Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Chief Executive Officer | 06/01/2017 |
Biogen GmbH
 Biogen GmbH Pharmaceuticals: MajorHealth Technology Discovers, develops, manufactures and supplies pharmaceutical products | Chief Executive Officer | - |
L’Institut de RYthmologie et Modélisation Cardiaque | Chairman | - |
n-Lorem Foundation
 n-Lorem Foundation Miscellaneous Commercial ServicesCommercial Services Operates as a non profit organization for nano-rare patients | Director/Board Member | - |
Revvity BV
 Revvity BV Medical SpecialtiesHealth Technology Manufactures and supplies laboratory equipment | Director/Board Member | - |
Former positions of Michel Vounatsos
| Companies | Position | End |
|---|---|---|
| BIOGEN INC. | Chief Executive Officer | 14/11/2022 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01/04/2016 |
Training of Michel Vounatsos
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
89
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Revvity, Inc.
 Revvity, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes reagents, analytical instruments and develops software | Health Technology |
École des Hautes Études Commerciales de Paris
 École des Hautes Études Commerciales de Paris Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Revvity BV
Revvity BV Medical SpecialtiesHealth Technology Manufactures and supplies laboratory equipment | Health Technology |
Biogen GmbH
Biogen GmbH Pharmaceuticals: MajorHealth Technology Discovers, develops, manufactures and supplies pharmaceutical products | Health Technology |
Zai Lab Ltd.
 Zai Lab Ltd. BiotechnologyHealth Technology Develops medicine for cancer, autoimmune and infectious diseases | Health Technology |
L’Institut de RYthmologie et Modélisation Cardiaque | |
n-Lorem Foundation
n-Lorem Foundation Miscellaneous Commercial ServicesCommercial Services Operates as a non profit organization for nano-rare patients | Commercial Services |
- Stock Market
- Insiders
- Michel Vounatsos
